CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net cash provided by operating activities (Note 6)	$ 141,534	$ 103,997
Cash flows from investing activities:
Capital expenditures	(29,973)	(46,356)
Origination of finance receivables	(736,801)	(907,769)
Collections on finance receivables	827,998	841,914
Other investing activities	171	(289)
Net cash provided (used) by investing activities	61,395	(112,500)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes	647,088	0
Repayments of securitization debt	(292,671)	(234,178)
Borrowings of asset-backed commercial paper	155,000	334,561
Repayments of asset-backed commercial paper	(65,004)	(46,154)
Net (decrease) increase in unsecured commercial paper	(140,778)	58,794
Net decrease in deposits	(37,439)	(6,758)
Dividends paid	(22,921)	(24,385)
Repurchase of common stock	(93,095)	(107,812)
Other financing activities	5	7
Net cash provided (used) by financing activities	150,185	(25,925)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	3,299	(7,020)
Net increase (decrease) in cash, cash equivalents and restricted cash	356,413	(41,448)
Cash, cash equivalents and restricted cash, beginning of period	1,740,854	1,648,811
Net increase (decrease) in cash, cash equivalents and restricted cash	356,413	(41,448)
Cash, cash equivalents and restricted cash, end of period	2,097,267	1,607,363
Reconciliation of cash, cash equivalents and restricted cash on the Consolidated balance sheets to the Consolidated statements of cash flows:
Cash and cash equivalents	1,931,175	1,464,614
Restricted cash	150,132	129,745
Restricted cash included in Other long-term assets	15,960	13,004
Cash, cash equivalents and restricted cash per the Consolidated statements of cash flows	$ 2,097,267	$ 1,607,363